Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology), MACG (USA)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Endocrinologist
M.B.B.S., M.D, Diplomate American Board Endocrinology , Diabetes and Metabolism, Diplomate American Board of Internal Medicine
Endocrinologist
M.B.B.S., M.D, Diplomate American Board Endocrinology , Diabetes and Metabolism, Diplomate American Board of Internal Medicine
Rheumatologist
MBBS, FCPS (Medicine), Fellowship in Rheumatology
Diabetologist
MBBS, MD (Internal Medicine), M.C.P.S
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Endocrinologist)
Internal Medicine Specialist
M.B.B.S. , PhD.
Diabetologist
MBBS, FCPS , MRCP, MRCP (UK), SCE Endocrinology and Diabetes (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures